The Indego Therapy lower-limb exoskeleton [Photo courtesy of Ekso Bionics]
The Indego exoskeleton deal includes all of Parker’s Human Motion and Control business and gives Ekso a new development partner.Ekso Bionics Holdings (Nasdaq:EKSO) has purchased the Indego exoskeleton line and the rest of Parker Hannifin’s Human Motion and Control (HMC) business unit.
The $10 million deal includes the planned development of robotic-assisted orthotic and prosthetic devices, the companies said in a news release provided to Medical Design & Outsourcing ahead of today’s announcement.
“The strategic acquisition of Parker’s uniquely-powered and adjustable Indego exoskeletons significantly builds our product offering and extends our market opportunity to the home,” Ekso Bionics Executive Chair Steven Sherman said in a statement. “With the addition of HMC, we intend to grow our global foot…